Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.90
Jun. 23, 2025 13:29:52- Change 0.012 (1.34831%)
- Volume 101,553
- Today's Open 0.89
- Previous Close 0.89
- Today's High 0.93
- Today's Low 0.89
- 52 Week High 4.3
- 52 Week Low 0.85